OCX logo

Oncocyte Corporation Common Stock


OCX: OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States.


Show OCX Financials

Consumer Interest
SEC Filings

Recent trades of OCX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by OCX's directors and management

Government lobbying spending instances

  • $19,000 Apr 15, 2021 Issue: Health Issues
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases


Number of mentions of OCX in WallStreetBets Daily Discussion

OCX News

Recent insights relating to OCX

CNBC Recommendations

Recent picks made for OCX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in OCX

Corporate Flights

Flights by private jets registered to OCX